Clive S. Grant

Clive S. Grant

Auto-generated profile, based on publicly available information

Clive S. Grant

Mayo Clinic

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
JSJohn M. Stulak
John M. Stulak
CGClive S. Grant
Clive S. Grant
DFDavid R. Farley
David R. Farley
GTGeoffrey B. Thompson
Geoffrey B. Thompson
JHJon A. van Heerden
Jon A. van Heerden
JCJ. William Charboneau
J. William Charboneau
For more than 2 decades, the most hotly contested surgical debate in the management of thyroid cancer was the extent of surgery: total vs near-total thyroidectomy vs unilateral lobectomy.1,2 Superseding this controversy since the turn of the 21st century has emerged the question of extent of associated lymph node dissection, particularly in papillary thyroid cancer (PTC), which represents nearly 90% of all thyroid cancers.

1 October 2005 in Best Practice & Research Clinical Gastroenterology
Verified
Journal Article
Closed access
CGClive S. Grant
Clive S. Grant

1 May 2005 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
CGClive S. Grant
Clive S. Grant
GTGeoffrey Thompson
Geoffrey Thompson
DFDavid Farley
David Farley
JHJon van Heerden
Jon van Heerden
Since the recommendations of the National Institutes of Health (NIH) Consensus Conference on asymptomatic primary hyperparathyroidism (HPT) were published in 19911 (Table 1), considerable new information has been published regarding symptoms of HPT,2,3 the disease influence on bone remodeling,4 and the marked improvements in both of these aspects following successful parathyroidectomy. Additionally, the dramatic sweeping changes spurred by minimally invasive techniques across all surgical disciplines fueled by extraordinarily rapid and widespread dissemination of information easily accessible via the Internet have driven new surgical approaches for parathyroidectomy. Incorporation of advances and refinements in technology, particularly in preoperative localization with sestamibi scintigraphy and intraoperative parathyroid hormone (IOPTH) level monitoring, has facilitated minimally invasive parathyroidectomy (MIP). Appropriately, many questions and concerns have been raised about such a drastic departure from the success of standard open, bilateral neck exploration: in excess of a 95% cure rate; rates of 1% or less for both hypoparathyroidism and recurrent laryngeal nerve paralysis; usually 1 night of hospitalization; and infrequent use of preoperative localization.5

1 May 2003 in Archives of Surgery
Verified
Journal Article
Closed access
PDF file
DBD. Kay Blanchard
D. Kay Blanchard
JDJohn H. Donohue
John H. Donohue
CRCarol Reynolds
Carol Reynolds
CGClive S. Grant
Clive S. Grant
Research from JAMA Surgery — Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast Cancer

1 February 2015
Verified
Journal Article
Open access
PDF file
CGClive S. Grant
Clive S. Grant
CSClive S.
Clive S.
Recurrence of papillary thyroid cancer after optimized surgery

10 December 2009 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CGClive S. Grant
Clive S. Grant
JSJohn M. Stulak
John M. Stulak
GTGeoffrey B. Thompson
Geoffrey B. Thompson
MRMelanie L. Richards
Melanie L. Richards
CRCarl C. Reading
Carl C. Reading
IHIan Hay
Ian Hay